We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Click here to add this to my saved trials
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Click here to add this to my saved trials
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Click here to add this to my saved trials
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Click here to add this to my saved trials
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Updated: 10/22/2015
Tube Versus Trabeculectomy (TVT) Study
Status: Enrolling
Updated: 10/22/2015
Click here to add this to my saved trials
Satisfaction With Multifocal vs Accommodating Lens Implants 2 Years After Surgery
Updated: 10/22/2015
Satisfaction With Multifocal vs Accommodating Lens Implants 2 Years After Surgery
Status: Enrolling
Updated: 10/22/2015
Satisfaction With Multifocal vs Accommodating Lens Implants 2 Years After Surgery
Updated: 10/22/2015
Satisfaction With Multifocal vs Accommodating Lens Implants 2 Years After Surgery
Status: Enrolling
Updated: 10/22/2015
Click here to add this to my saved trials
IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD
Updated: 10/25/2015
Intense Pulsed Light (IPL) and Meibomian Gland Expression to Treat Ocular Rosacea Secondary to Inactive Chronic Ocular Graft Versus Host Disease (GVHD)
Status: Enrolling
Updated: 10/25/2015
IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD
Updated: 10/25/2015
Intense Pulsed Light (IPL) and Meibomian Gland Expression to Treat Ocular Rosacea Secondary to Inactive Chronic Ocular Graft Versus Host Disease (GVHD)
Status: Enrolling
Updated: 10/25/2015
Click here to add this to my saved trials
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
Updated: 10/26/2015
A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
LME636 in the Relief of Persistent Ocular Discomfort in Patients With Severe Dry Eye Disease
Updated: 10/27/2015
A Randomized, Double-masked, Vehicle-controlled Study of LME636 in the Relief of Persistent Ocular Discomfort in Patients With Severe Dry Eye Disease
Status: Enrolling
Updated: 10/27/2015
LME636 in the Relief of Persistent Ocular Discomfort in Patients With Severe Dry Eye Disease
Updated: 10/27/2015
A Randomized, Double-masked, Vehicle-controlled Study of LME636 in the Relief of Persistent Ocular Discomfort in Patients With Severe Dry Eye Disease
Status: Enrolling
Updated: 10/27/2015
Click here to add this to my saved trials
Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner
Updated: 10/27/2015
Pediatric Vision Scanner for the Eradication of Amblyopia
Status: Enrolling
Updated: 10/27/2015
Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner
Updated: 10/27/2015
Pediatric Vision Scanner for the Eradication of Amblyopia
Status: Enrolling
Updated: 10/27/2015
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Updated: 10/28/2015
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Updated: 10/28/2015
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Updated: 10/28/2015
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Updated: 10/28/2015
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Updated: 10/28/2015
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Updated: 10/28/2015
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
Updated: 10/28/2015
A Phase IV Open Label Trial of the Safety, Tolerability and Efficacy of 0.5mg Ranibizumab Intravitreal Injections Combined With Wide Field Angiography Guided Panretinal Photocoagulation vs. 0.5mg Ranibizumab Intravitreal Injection Monotherapy in Subjects With Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Who Incompletely Respond to at Least 2 Consecutive Intravitreal Injections in the Past 4 Months.
Status: Enrolling
Updated: 10/28/2015
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
Updated: 10/28/2015
A Phase IV Open Label Trial of the Safety, Tolerability and Efficacy of 0.5mg Ranibizumab Intravitreal Injections Combined With Wide Field Angiography Guided Panretinal Photocoagulation vs. 0.5mg Ranibizumab Intravitreal Injection Monotherapy in Subjects With Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Who Incompletely Respond to at Least 2 Consecutive Intravitreal Injections in the Past 4 Months.
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
Updated: 10/28/2015
A Phase IV Open Label Trial of the Safety, Tolerability and Efficacy of 0.5mg Ranibizumab Intravitreal Injections Combined With Wide Field Angiography Guided Panretinal Photocoagulation vs. 0.5mg Ranibizumab Intravitreal Injection Monotherapy in Subjects With Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Who Incompletely Respond to at Least 2 Consecutive Intravitreal Injections in the Past 4 Months.
Status: Enrolling
Updated: 10/28/2015
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
Updated: 10/28/2015
A Phase IV Open Label Trial of the Safety, Tolerability and Efficacy of 0.5mg Ranibizumab Intravitreal Injections Combined With Wide Field Angiography Guided Panretinal Photocoagulation vs. 0.5mg Ranibizumab Intravitreal Injection Monotherapy in Subjects With Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Who Incompletely Respond to at Least 2 Consecutive Intravitreal Injections in the Past 4 Months.
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
Updated: 10/28/2015
A Phase IV Open Label Trial of the Safety, Tolerability and Efficacy of 0.5mg Ranibizumab Intravitreal Injections Combined With Wide Field Angiography Guided Panretinal Photocoagulation vs. 0.5mg Ranibizumab Intravitreal Injection Monotherapy in Subjects With Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Who Incompletely Respond to at Least 2 Consecutive Intravitreal Injections in the Past 4 Months.
Status: Enrolling
Updated: 10/28/2015
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
Updated: 10/28/2015
A Phase IV Open Label Trial of the Safety, Tolerability and Efficacy of 0.5mg Ranibizumab Intravitreal Injections Combined With Wide Field Angiography Guided Panretinal Photocoagulation vs. 0.5mg Ranibizumab Intravitreal Injection Monotherapy in Subjects With Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Who Incompletely Respond to at Least 2 Consecutive Intravitreal Injections in the Past 4 Months.
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Comparison of Two Marketed Silicone Hydrogel Lenses
Updated: 10/28/2015
One Month Clinical Comparison of Lotrafilcon B and Samfilcon A
Status: Enrolling
Updated: 10/28/2015
Comparison of Two Marketed Silicone Hydrogel Lenses
Updated: 10/28/2015
One Month Clinical Comparison of Lotrafilcon B and Samfilcon A
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Updated: 10/28/2015
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Status: Enrolling
Updated: 10/28/2015
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Updated: 10/28/2015
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Updated: 10/29/2015
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 10/30/2015
Updated: 10/30/2015
Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 10/30/2015
Updated: 10/30/2015
Click here to add this to my saved trials
Use of "Smart Wheelchairs" to Provide Independent Mobility to Visual and Mobility Impairments
Updated: 10/30/2015
Use of "Smart Wheelchairs" to Provide Independent Mobility to Visual and Mobility Impairments
Status: Enrolling
Updated: 10/30/2015
Use of "Smart Wheelchairs" to Provide Independent Mobility to Visual and Mobility Impairments
Updated: 10/30/2015
Use of "Smart Wheelchairs" to Provide Independent Mobility to Visual and Mobility Impairments
Status: Enrolling
Updated: 10/30/2015
Click here to add this to my saved trials
Use of "Smart Wheelchairs" to Provide Independent Mobility to Visual and Mobility Impairments
Updated: 10/30/2015
Use of "Smart Wheelchairs" to Provide Independent Mobility to Visual and Mobility Impairments
Status: Enrolling
Updated: 10/30/2015
Use of "Smart Wheelchairs" to Provide Independent Mobility to Visual and Mobility Impairments
Updated: 10/30/2015
Use of "Smart Wheelchairs" to Provide Independent Mobility to Visual and Mobility Impairments
Status: Enrolling
Updated: 10/30/2015
Click here to add this to my saved trials
Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Updated: 11/3/2015
Infliximab Therapy to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis
Status: Enrolling
Updated: 11/3/2015
Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Updated: 11/3/2015
Infliximab Therapy to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis
Status: Enrolling
Updated: 11/3/2015
Click here to add this to my saved trials
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
Updated: 11/3/2015
A 10 Month, Single Masked, Randomized Controlled Study to Assess Anti-VEGF Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
Status: Enrolling
Updated: 11/3/2015
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
Updated: 11/3/2015
A 10 Month, Single Masked, Randomized Controlled Study to Assess Anti-VEGF Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
Status: Enrolling
Updated: 11/3/2015
Click here to add this to my saved trials
B-Receptor Signaling in Cardiomyopathy
Updated: 11/16/2015
B-Receptor Signaling in Cardiomyopathy
Status: Enrolling
Updated: 11/16/2015
B-Receptor Signaling in Cardiomyopathy
Updated: 11/16/2015
B-Receptor Signaling in Cardiomyopathy
Status: Enrolling
Updated: 11/16/2015
Click here to add this to my saved trials
Click here to add this to my saved trials
Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants
Updated: 11/17/2015
Newborn Vitamin A Supplementation, Gut Microbiota and Vaccine Response During the Second Year of Life in Bangladeshi Infants
Status: Enrolling
Updated: 11/17/2015
Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants
Updated: 11/17/2015
Newborn Vitamin A Supplementation, Gut Microbiota and Vaccine Response During the Second Year of Life in Bangladeshi Infants
Status: Enrolling
Updated: 11/17/2015
Click here to add this to my saved trials
Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants
Updated: 11/17/2015
Newborn Vitamin A Supplementation, Gut Microbiota and Vaccine Response During the Second Year of Life in Bangladeshi Infants
Status: Enrolling
Updated: 11/17/2015
Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants
Updated: 11/17/2015
Newborn Vitamin A Supplementation, Gut Microbiota and Vaccine Response During the Second Year of Life in Bangladeshi Infants
Status: Enrolling
Updated: 11/17/2015
Click here to add this to my saved trials
Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants
Updated: 11/17/2015
Newborn Vitamin A Supplementation, Gut Microbiota and Vaccine Response During the Second Year of Life in Bangladeshi Infants
Status: Enrolling
Updated: 11/17/2015
Vitamin A, Stool Microbiota and Vaccine Response in Bangladeshi Infants
Updated: 11/17/2015
Newborn Vitamin A Supplementation, Gut Microbiota and Vaccine Response During the Second Year of Life in Bangladeshi Infants
Status: Enrolling
Updated: 11/17/2015
Click here to add this to my saved trials
Patient Perception of Visual Distortions
Status: Enrolling
Updated: 11/18/2015
Updated: 11/18/2015
Patient Perception of Visual Distortions
Status: Enrolling
Updated: 11/18/2015
Updated: 11/18/2015
Click here to add this to my saved trials
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Updated: 11/19/2015
A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials